• Japanese
  • Korean
  • Chinese
Cover Image

Global Intravenous Solutions Market 2014-2018

TechNavio forecasts Power Cables Market in China 2014-2018 with a CAGR of 8.08 percent for the period 2013-2018. Several driving factors and trends will contribute to this growth-all of which will be outlined with detail in this report.

TechNavio's analysts use a unique methodology to scrutinize individual vendor performance, trends, drivers and challenges, and a number of other factors to provide the most accurate and detailed market research reports possible.

A more specific breakdown of this report's contents is below.

Overview and impact analysis of:

  • 3 Market Drivers
  • 3 Market Challenges
  • 3 Market Trends

Vendor Profile and SWOT Analysis for these vendors:

  • Far East Cable Co. Ltd.
  • Nexans S.A.
  • Prysmian S.p.A.
  • Shandong Wanda Cable Co. Ltd.

Five Force Model Impact Analysis of:

  • Suppliers
  • Buyers
  • Substitutes
  • New entrants
  • Market competition

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Geographical Segmentation

  • 07.1. Intravenous Solutions Market in the Americas
    • 07.1.1. Market Size and Forecast
  • 07.2. Intravenous Solutions Market in the EMEA Region
    • 07.2.1. Market Size and Forecast
  • 07.3. Intravenous Solutions Market in the APAC Region
    • 07.3.1. Market Size and Forecast

08. Key Leading Countries

  • 08.1. Key Leading Countries in the Americas
    • 08.1.1. USA
  • 08.2. Key Leading Countries in the EMEA Region
    • 08.2.1. Germany
    • 08.2.2. UK
  • 08.3. Key Leading Countries in the APAC Region
    • 08.3.1. Japan
    • 08.3.2. China

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

  • 16.1. Competitive Scenario
    • 16.1.1. Key News
    • 16.1.2. Mergers and Acquisitions
  • 16.2. Market Share Analysis 2013
  • 16.3. Other Prominent Vendors

17. Key Vendor Analysis

  • 17.1. B. Braun Melsungen AG
    • 17.1.1. Business Overview
    • 17.1.2. Business Segmentation
    • 17.1.3. Key Information
    • 17.1.4. SWOT Analysis
  • 17.2. Baxter International Inc.
    • 17.2.1. Business Overview
    • 17.2.2. Business Segmentation
    • 17.2.3. Key Information
    • 17.2.4. SWOT Analysis
  • 17.3. Fresenius Kabi AG
    • 17.3.1. Business Overview
    • 17.3.2. Business Segmentation
    • 17.3.3. Key Information
    • 17.3.4. SWOT Analysis
  • 17.4. Hospira Inc.
    • 17.4.1. Business Overview
    • 17.4.2. Business Segmentation
    • 17.4.3. Key Information
    • 17.4.4. SWOT Analysis

18. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Intravenous Solutions Market 2013-2018 (US$ billion)
  • Exhibit 3: Global Intravenous Solutions Market by Geographical Segmentation 2013
  • Exhibit 4: Intravenous Solutions Market in the Americas 2013-2018 (US$ billion)
  • Exhibit 5: Intravenous Solutions Market in the EMEA Region 2013-2018 (US$ billion)
  • Exhibit 6: Intravenous Solutions Market in the APAC Region 2013-2018 (US$ billion)
  • Exhibit 7: Global Intravenous Solutions Market by Vendor Segmentation 2013
  • Exhibit 8: Business Segmentation of B. Braun Melsungen AG
  • Exhibit 9: Business Segmentation of Baxter International Inc.
  • Exhibit 10: Business Segmentation of Fresenius Kabi AG
  • Exhibit 11: Business Segmentation of Hospira Inc.
Show More
Pricing
Get Notified
Email me when related reports are published